A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients
Clinical trial NCT05725018 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05725018
- Sponsor
- Abeona Therapeutics, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-02
- Primary completion
- 2025-09-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.